Revive Therapeutics Ltd (RVV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 1,649 | 3,286 | 5,521 | 17,833 | 18,592 |
| Operating Income | -1,649 | -3,286 | -5,521 | -17,833 | -18,592 |
| Interest Expense | 1 | 20 | 44 | 63 | 79 |
| Other Income | -9,362 | -2,312 | -756 | 90 | -1,447 |
| Pre-tax Income | -11,011 | -5,619 | -6,321 | -17,807 | -20,119 |
| Net Income Continuous | -11,011 | -5,619 | -6,321 | -17,807 | -20,119 |
| Net Income | $-11,011 | $-5,619 | $-6,321 | $-17,807 | $-20,119 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 |
| EBITDA(a) | $-11,010 | $-5,598 | $-6,276 | $-17,743 | $-20,039 |